YTHDF3敲低前后三阴性乳腺癌细胞非标记定量蛋白质组学差异分析OA
A Label-Free Differential Quantitative Proteomics Analysis of Triple-Negative Breast Cancer Cells Before and After YTHDF3 Knockdown
目的 分析三阴性乳腺癌(triple negative breast cancer,TNBC)细胞敲低YTHDF3(YT521-B homology domain family 3)前后的蛋白质表达差异,探究YTHDF3调控TNBC细胞蛋白质功能的可能机制.方法 利用分子克隆、靶点设计和病毒载体包装技术构建YTHDF3稳定敲低的MDA-MB-231细胞系并采用Western blot法进一步验证.裂解细胞蛋白,采用超高效液相色谱(ultra performance liquid chromatography,UPLC)和液相色谱-串联质谱(liquid chromatography-tandem mass spectrometry,LC-MS/MS)方法获取因敲低YTHDF3而出现的差异表达蛋白.使用String数据库及Cytoscape 3.10.1软件,绘制并分析蛋白质互作网络(protein-protein interaction,PPI)并筛选核心靶点.通过David数据库对核心靶点进行京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)通路和基因本体(gene ontology,GO)功能富集分析.采用RNA干扰技术分别敲低MDA-MB-231和HS-578T细胞中的YTHDF3或UUbiquitin(BBB)基因,Western blot法验证YTHDF3敲低的两种TNBC细胞中核心靶蛋白的表达,并采用Transwell法检测UBB敲低对TNBC细胞侵袭和迁移的影响.结果 成功构建了YTHDF3稳定敲低的TNBC细胞模型,并在该细胞中定量到2 295个蛋白,筛选出261个差异表达蛋白(126种下调和135种上调).GO分析结果显示,差异下调蛋白主要涉及翻译和蛋白质稳定性,而对细胞群体增殖的负调控蛋白则是上调表达.KEGG结果表明,差异下调蛋白主要富集于剪接体相关信号通路,而差异上调蛋白主要与凋亡通路相关.PPI分析表明有6个核心靶点(RPS27A、UBA52、UBC、UBB、RPL4和RPS2)下调.Western blot分析揭示YTHDF3敲低的MDA-MB-231和HS-578T细胞中YTHDF3和UBB蛋白表达均降低.Transwell结果指出UBB缺失抑制TNBC细胞侵袭和迁移水平.结论 本文以全新视角的研究,揭示了YTHDF3通过调控下游核心靶点UBB在TNBC细胞侵袭转移中发挥着重要作用.
Objective This study aimed to analyze the protein expression differences of triple negative breast cancer(TNBC)cells before and after YTHDF3 knockdown and explore the possible mechanisms by which YTHDF3 regulates protein function in TNBC cells.Methods The YTHDF3 stably knocked down MDA-MB-231 cell lines were constructed using molecular cloning,target design and viral vector packaging techniques and further validated by Western blot.We cleaved the proteins and obtained the differentially expressed proteins caused by knockdown of YTHDF3 using Ultra Performance Liquid Chromatography(UPLC)and Liquid Chromatography-Tandem Mass Spectrometry(LC-MS/MS)methods.Then,protein-protein interaction(PPI)networks were mapped and analyzed using the String database and Cytoscape 3.10.1 software,and core targets were screened.The core targets were analyzed for Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway and Gene Ontology(GO)functional enrichment through the David database.RNA interference was applied to knock down YTHDF3 or UBB gene in MDA-MB-231 and HS-578T cells,respectively.The expression of core target proteins in the two TNBC cells with YTHDF3 knockdown was verified by Western blot.Finally,the impact of UBB(Ubiquitin B)knockdown on the invasion and migration of TNBC cells was detected by Transwell assay.Results We successfully constructed a TNBC cell model with stably YTHDF3 knockdown and quantified 2 295 proteins as well as screened 261 differentially expressed proteins(126 down-regulated and 135 up-regulated).GO analysis showed that the differentially down-regulated proteins were mainly involved in translation and protein stabilization,while the differentially up-regulated proteins were mainly associated with negative regulation of cell population proliferation.KEGG results indicated that the differentially down-regulated proteins were mainly enriched in spliceosome-related signaling pathways,whereas differentially up-regulated proteins were mainly relevant to apoptosis-related pathways.The PPI analysis revealed that six core targets(RPS27A,UBA52,UBC,UBB,RPL4,and RPS2)were all down-regulated.Western blot analysis uncovered decreased expression of both YTHDF3 and UBB proteins in YTHDF3 knockdown MDA-MB-231 and HS-578T cells.Transwell results indicated that deficient UBB inhibited the invasion and migration levels of TNBC cells.Conclusions YTHDF3 plays a crucial role in the invasion and metastasis of TNBC cells by regulating the downstream core target UBB.
WANG Kai;LIN Yangyi;LI Qinlian;SUN Yuhang;ZHENG Yuhang;JIANG Yihan;DONG Wenjuan;MEI Zhiqiang
Key Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,ChinaKey Laboratory of Epigenetics and Oncology,Research Center for Preclinical Medicine,Southwest Medical University,Luzhou 646000,China
医药卫生
YTHDF3敲低三阴性乳腺癌蛋白质组学差异分析
YTHDF3KnockdownTriple negative breast cancerProteomicsDifferential analysis
《西南医科大学学报》 2026 (1)
50-59,10
四川省科技厅项目(2023NSFSC0741)泸州市-西南医科大学科技战略合作项目(2024LZXNYDJ092)国家级大学生创新创业训练项目(202310632104)校级大学生创新创业项目(2024317)
评论